| 标题 |
Comparative cost-effectiveness of ribociclib and palbociclib as first-line treatment for HR+/HER2– advanced breast cancer in postmenopausal women: analysis from a Medicare perspective |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medical Economics 作者:Sarah Sammons; Paolo Tarantino; V. K. Gadi; Purnima Pathak; Gary Sopher; et al 出版日期:2025-12-09 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)